InMed Pharmaceuticals, Inc. (INM)
1.73
+0.12
(+7.45%)
USD |
NASDAQ |
May 21, 16:00
1.77
+0.04
(+2.31%)
Pre-Market: 08:22
InMed Pharmaceuticals Shareholders Equity (Quarterly) : 6.892M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CannaPharmaRx, Inc. | -30.27M |
| Lexaria Bioscience Corp. | 6.602M |
| Target Group, Inc. (Canada) | -8.544M |
| Tilray Brands, Inc. | 1.557B |
| NervGen Pharma Corp. | 3.971M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.134M |
| Total Liabilities (Quarterly) | 2.242M |
| Debt to Equity Ratio | 0.061 |
| Current Ratio | 3.115 |
| Net Debt Paydown Yield | 4.95% |